Drug Database
Back to search

United States· US:0456-1510_c8829ba6-79a8-476e-8cf1-eb30641287c1

Savella

A medicinal product containing milnacipran hydrochloride, registered in United States by Allergan, Inc..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedSavellaATC—REGISTER NO.US:0456-1510_c8829ba6…PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about milnacipran hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
milnacipran hydrochloride
Manufacturer
Allergan, Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 12, 2026

Packs & prices · 1

  • ndc11
    0456151060
    60 TABLET, FILM COATED in 1 BOTTLE (0456-1510-60)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Milnacipran hydrochloride in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All milnacipran hydrochloride products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Austria · Milnacipran Glenmark, Milnacipran Rivopharm
  • Germany · Milnacipran Glenmark, Milnacipran Holsten
  • France · Milnacipran Arrow, Milnacipran Eg
  • Luxembourg · Milnacipran Micro Labs

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f94db7e8-ba38-4b57-aa9f-9ffe8ff2e83f
GET /v1/drugs/f94db7e8-ba38-4b57-aa9f-9ffe8ff2e83f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "livertox": {
    "summary": null,
    "livertox_id": null,
    "hepatotoxicity_score": 4
  },
  "productid": "0456-1510_c8829ba6-79a8-476e-8cf1-eb30641287c1",
  "productndc": "0456-1510",
  "dosage_form": "TABLET, FILM COATED",
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "MILNACIPRAN HYDROCHLORIDE",
  "proprietary_name": "Savella",
  "active_ingred_unit": "mg/1",
  "application_number": "NDA022256",
  "marketing_category": "NDA",
  "nonproprietary_name": "milnacipran hydrochloride",
  "start_marketing_date": "20090417",
  "active_numerator_strength": "100"
}
API referenceMCP serverPlans

See everything about milnacipran hydrochloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console